Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by Monaco21on Sep 15, 2020 5:44pm
141 Views
Post# 31564298

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Summer sale sold out Bioteck

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Summer sale sold out Bioteck

No one is diluting the shares, it is about gaining momentum, and for that to happen, capital is raised. This is basic economics. And no need to spread misinformation. Stick to the facts, only (Re: shares owned by management).

Also, research is not free and capital is needed for this. If there is no capital, there is no research, and then… what are we all doing here? Negative thoughts and fear based assumptions bring nothing: Nobody said diabetes is simple to solve, hence the extensive research. It seems like biotek and some other investors do not believe in this company. There are many other investment options, folks. Research and clinical results take time. If you are in a hurry to make a quick dollar, perhaps other investment vehicles might be more suitable for you.

 
Bullboard Posts